1. A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy
- Author
-
Tadahiro Shoji, Ryosuke Takeshita, Tatsunori Saito, Takeshi Aida, Shunichi Sasou, and Tsukasa Baba
- Subjects
Ovarian cancer ,Signet-ring cell carcinoma ,S-1 ,CDDP ,Gynecology and obstetrics ,RG1-991 - Abstract
Abstract Background Primary ovarian signet-ring cell carcinoma is extremely rare, with only five recent case reports. Almost all reported cases of ovarian signet-ring cell carcinoma have been treated with TC therapy and none have reported regarding the use of S-1/CDDP therapy. We report a case of primary ovarian signet-ring cell carcinoma treated postoperatively with S-1/CDDP therapy. Case presentation We describe a 55-year-old woman diagnosed with stage IB primary ovarian signet-ring cell carcinoma that was treated with S-1/CDDP therapy. Preoperative transvaginal ultrasonography and contrast-enhanced computed tomography (CT) revealed a solid tumor measuring 10 cm in diameter in the pelvis. The tumor marker levels were as follows: CA125, 41.6 U/mL; CA19–9,
- Published
- 2020
- Full Text
- View/download PDF